Abstract: The generation of industrial process flow charts is crucial in modern production, but traditional deep learning models struggle with inconsistent formats, terminology variations, and noisy ...

Reliance Industries, the heavyweight of Dalal Street, is set to announce its Q3 earnings today, and the numbers could decide market direction for the coming week. Expectations are high as investors ...

Learn how to tell if your business could be facing a cash crunch—and what to do about it Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

It can also locate your pet while you’re away from home. It can also locate your pet while you’re away from home. is a news writer who covers the streaming wars, consumer tech, crypto, social media, ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...

FLOW dropped nearly 14% as a recent exploit continues weighing on investor confidence. Major exchanges suspended FLOW services, adding pressure to the token's price. Flow’s team is now rolling out a ...

The Flow FL-100 headset, recently cleared by the FDA, uses a low electrical current to stimulate a part of the brain involved in mood regulation. The Flow FL-100 was recently okayed by the U.S. Food ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...